Cytosorbents (CTSO) News Today → BUY ALERT: Tiny tech play partners with US government (From Stansberry Research) (Ad) Free CTSO Stock Alerts $0.88 +0.06 (+7.32%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europefinance.yahoo.com - May 2 at 8:40 AMCytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - May 2 at 5:24 AMCytosorbents (CTSO) Set to Announce Earnings on Thursdayamericanbankingnews.com - May 2 at 4:24 AMCytoSorbents to Report First Quarter 2024 Operating and Financial Resultsglobenewswire.com - April 26 at 7:00 AMSTAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meetingfinance.yahoo.com - April 17 at 10:40 AMCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2024.finance.yahoo.com - April 4 at 3:46 PMCTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2023.finance.yahoo.com - April 4 at 10:45 AMCytosorbents Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 16 at 1:06 PMCTSO Apr 2024 2.500 callfinance.yahoo.com - March 16 at 8:06 AMQ4 2023 Cytosorbents Corp Earnings Callfinance.yahoo.com - March 15 at 11:19 AMCytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 11:19 AMRecap: CytoSorbents Q4 Earningsbenzinga.com - March 14 at 9:01 PMCytoSorbents Reports Fourth Quarter and Full Year 2023 Resultsglobenewswire.com - March 14 at 4:39 PMCytosorbents earnings preview: what to expectmarkets.businessinsider.com - March 13 at 11:54 PMCytoSorbents to Report Fiscal 2023 Operating and Financial Resultsglobenewswire.com - March 6 at 7:00 AMCTSO Mar 2024 2.500 callfinance.yahoo.com - March 4 at 10:03 AMCytosorbents Corpmoney.usnews.com - February 27 at 9:50 AMCytosorbents (NASDAQ:CTSO) investors are sitting on a loss of 90% if they invested three years agofinance.yahoo.com - February 23 at 9:47 AMCytoSorbents Stock (NASDAQ:CTSO) Insider Tradesbenzinga.com - February 22 at 7:45 PMCytoSorbents Stock (NASDAQ:CTSO) Dividends: History, Yield and Datesbenzinga.com - February 22 at 7:45 PMCytoSorbents to Present at the TD Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 8 at 10:01 AMCTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.finance.yahoo.com - January 17 at 3:56 PMGroundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patientsfinance.yahoo.com - January 17 at 10:04 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSOstockhouse.com - January 6 at 2:53 PMHC Wainwright & Co. Downgrades Cytosorbents (CTSO)msn.com - December 30 at 9:03 AMCytoSorbents Holds Steady with Neutral Rating Amid Clinical and Financial Reassessmentsmarkets.businessinsider.com - December 30 at 9:03 AMCytoSorbents just downgraded at H.C. Wainwright, here's whyrealmoney.thestreet.com - December 29 at 7:17 PMWhat To Know About HC Wainwright & Co.'s Downgrade of CytoSorbentsmarkets.businessinsider.com - December 29 at 2:17 PMCytoSorbents: DrugSorb-ATR Study Fails To Meet Primary Effectiveness Endpointmarkets.businessinsider.com - December 28 at 9:11 AMCytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendationfinance.yahoo.com - December 28 at 9:11 AMInsider Spends US$100k Buying More Shares In Cytosorbentsfinance.yahoo.com - December 18 at 9:50 AMInsider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)finance.yahoo.com - December 16 at 9:46 AMCytoSorbents Announces Closing of $10.3 Million Registered Direct Offeringfinance.yahoo.com - December 13 at 12:33 PMCTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.finance.yahoo.com - November 14 at 3:26 PMCytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcriptseekingalpha.com - November 12 at 2:33 PMCytoSorbents: Q3 Earnings Snapshotwashingtonpost.com - November 9 at 6:19 PMCytoSorbents Reports Third Quarter 2023 Financial and Operational Resultsfinance.yahoo.com - November 9 at 6:19 PMHere's what Wall Street expects from Cytosorbents's earnings reportmarkets.businessinsider.com - November 8 at 10:17 AMCytoSorbents to Report Third Quarter 2023 Operating and Financial Resultsfinance.yahoo.com - October 27 at 9:46 AMCytoSorbents to Present at the 8th Annual Dawson James Conferencefinance.yahoo.com - October 5 at 9:41 AMCytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registryfinance.yahoo.com - September 27 at 7:34 AMCytoSorbents Announces Reappointment Of Kathleen Bloch As Full-time CFOmarkets.businessinsider.com - September 19 at 10:17 AMCytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officerfinance.yahoo.com - September 19 at 10:17 AMCytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantationfinance.yahoo.com - September 11 at 3:16 PMQ3 2023 Earnings Forecast for Cytosorbents Co. (NASDAQ:CTSO) Issued By B. Rileymarketbeat.com - September 8 at 10:36 AMCytoSorbents announces resignation of CFO Alexander D'Amicoseekingalpha.com - September 2 at 11:46 PMCytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amicofinance.yahoo.com - September 1 at 8:41 PMCytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazilfinance.yahoo.com - August 31 at 7:26 AMCytosorbents (NASDAQ:CTSO) shareholders have endured a 83% loss from investing in the stock five years agofinance.yahoo.com - August 27 at 6:46 PMCytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trialfinance.yahoo.com - August 14 at 5:50 PM Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… CTSO Media Mentions By Week CTSO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.290.43▲Average Medical News Sentiment CTSO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼31▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LUCD News Today NSPR News Today DRIO News Today GBS News Today XAIR News Today CTCX News Today APYX News Today CODX News Today ICU News Today LNSR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial MetalsWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
